title: Attempted experimental modification of the postlaminectomy membrane by local instillation of recombinant tissue-plasminogen activator gel.
abstract: A prospective, randomized, blinded trial involving 25 adult mongrel dogs was performed to evaluate whether placement of a fat graft or local instillation of recombinant tissue-plasminogen activator gel (rt-PA) could modify the development of a postlaminectomy membrane. One component of the study involved the performance of a lumbar laminectomy and placement of gel rt-PA, free fat, or no tissue placement over the exposed dura mater. Three months later the animals were killed and sections of spine were removed en bloc, decalcified, and examined histologically. No significant differences were found in the degree of cellular fibrosis or heavy collagen production. A similar laminectomy at another lumbar level was also followed by gel rt-PA, free fat, or no tissue placement. Three months after surgery, surgery was performed again at this level immediately before death. There were no differences in the adhesiveness of the laminectomy membrane to dura mater or roots. It was concluded that the local instillation of gel rt-PA after laminectomy did not inhibit scar formation or scar adherence to the dura mater.
authors.affiliation: Department of Surgery, University of Alberta, Faculty of Medicine, Edmonton, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Henderson
authors.forename: B
authors.initials: B
authors.lastname: Weir
authors.forename: L
authors.initials: L
authors.lastname: Davis
authors.forename: B
authors.initials: B
authors.lastname: Mielke
authors.forename: M
authors.initials: M
authors.lastname: Grace
mesh_terms: D000273:Adipose Tissue / Q000637:transplantation*; D000818:Animals; D002921:Cicatrix / Q000473:pathology / Q000517:prevention & control* / Q000601:surgery; D004285:Dogs; D005260:Female; D007796:Laminectomy; D008297:Male; D011183:Postoperative Complications / Q000473:pathology / Q000517:prevention & control* / Q000601:surgery; D011446:Prospective Studies; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D010959:Tissue Plasminogen Activator